Letter to the editor: radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers

A commentary on the original research article: ‘Radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers’. Of note, the predictor selection process, the cross-validation method, along with the lack of final testing of the developed model with a separated data s...

Descripción completa

Detalles Bibliográficos
Autores principales: Cunha, Mateus Trinconi, Carvalho, Vinicius Jardim, Loureiro, Rafael Maffei, Brantis-de-Carvalho, Carlos Eduardo, Cintra, Murilo Bicudo, de Castro Junior, Gilberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317071/
https://www.ncbi.nlm.nih.gov/pubmed/34315822
http://dx.doi.org/10.1136/jitc-2021-003044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317071/
https://www.ncbi.nlm.nih.gov/pubmed/34315822
http://dx.doi.org/10.1136/jitc-2021-003044

Ejemplares similares